CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
+18.11%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$514M
AUM Growth
+$169M
(+49%)
Cap. Flow
+$116M
Cap. Flow
% of AUM
22.65%
Top 10 Holdings %
Top 10 Hldgs %
26.88%
Holding
503
New
57
Increased
239
Reduced
90
Closed
78
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$6.88M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$6.46M |
| 3 |
Gilead Sciences
GILD
|
$6.38M |
| 4 |
Amgen
AMGN
|
$6.24M |
| 5 |
Adobe
ADBE
|
$5.19M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$5.18M |
| 2 |
Analog Devices
ADI
|
$3.75M |
| 3 |
Amazon
AMZN
|
$3.48M |
| 4 |
lululemon athletica
LULU
|
$3.4M |
| 5 |
iQIYI
IQ
|
$1.91M |
Sector Composition
| 1 | Technology | 34.39% |
| 2 | Healthcare | 30.05% |
| 3 | Consumer Discretionary | 17.55% |
| 4 | Communication Services | 6.11% |
| 5 | Consumer Staples | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Acumen Pharmaceuticals
ABOS
$87.2M
| – | – |
-1,481
| Closed | -$6.15K |
|
427
Absci
ABSI
$368M
| – | – |
-2,383
| Closed | -$3.15K |
|
428
Adicet Bio
ACET
$60M
| – | – |
-1,103
| Closed | -$1.51K |
|
|
ADAP
429
Adaptimmune Therapeutics
ADAP
$10.9M
| – | – |
-5,285
| Closed | -$4.12K |
|
|
AFMD
430
DELISTED
Affimed
AFMD
| – | – |
-383
| Closed | -$1.83K |
|
|
ALLK
431
DELISTED
Allakos
ALLK
| – | – |
-2,225
| Closed | -$5.05K |
|
432
Altimmune
ALT
$334M
| – | – |
-1,354
| Closed | -$3.52K |
|
433
Annexon
ANNX
$238M
| – | – |
-1,368
| Closed | -$3.23K |
|
434
Atara Biotherapeutics
ATRA
$90.7M
| – | – |
-104
| Closed | -$3.83K |
|
435
BioAtla
BCAB
$31.5M
| – | – |
-1,219
| Closed | -$2.07K |
|
436
C4 Therapeutics
CCCC
$194M
| – | – |
-1,269
| Closed | -$2.36K |
|
437
Codexis
CDXS
$218M
| – | – |
-1,790
| Closed | -$3.38K |
|
|
CMPS
438
Compass Pathways
CMPS
$493M
| – | – |
-690
| Closed | -$5.11K |
|
439
Inovio Pharmaceuticals
INO
$148M
| – | – |
-574
| Closed | -$2.68K |
|
440
Century Therapeutics
IPSC
$43.6M
| – | – |
-1,528
| Closed | -$3.06K |
|
441
Invivyd
IVVD
$239M
| – | – |
-2,816
| Closed | -$4.79K |
|
442
Mersana Therapeutics
MRSN
$34M
| – | – |
-124
| Closed | -$3.93K |
|
443
Nektar Therapeutics
NKTR
$764M
| – | – |
-325
| Closed | -$2.91K |
|
444
Nkarta
NKTX
$161M
| – | – |
-1,265
| Closed | -$1.76K |
|
445
Omeros
OMER
$284M
| – | – |
-1,619
| Closed | -$4.73K |
|
|
OPTN
446
DELISTED
OptiNose
OPTN
| – | – |
-192
| Closed | -$3.54K |
|
447
Oracle
ORCL
$654B
| – | – |
-18,000
| Closed | -$1.91M |
|
448
PepGen
PEPG
$45.9M
| – | – |
-615
| Closed | -$3.12K |
|
449
PMV Pharmaceuticals
PMVP
$77.4M
| – | – |
-1,251
| Closed | -$7.68K |
|
450
Quantum-Si Incorporated
QSI
$219M
| – | – |
-3,127
| Closed | -$5.19K |
|